Bo Johansson

TL;DR: The addition of an HPV test to the Pap test to screen women in their mid-30s for cervical cancer reduces the incidence of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected by subsequent screening examinations.

TL;DR: Primary HPV DNA-based screening with cytology triage and repeat HPV DNA testing of cytology-negative women appears to be the most feasible cervical screening strategy.

TL;DR: The conclusion is that in PCR detection systems, multiple consensus primers and type-specific primers should be used in order to detect all patients harboring HPV.

TL;DR: It is concluded that the virus does not really travel along with malignant lymphomas as a passenger in the seropositive patients, and the EBNA antigen test appears a relatively simple way of testing for the presence of the virus genome, provided it is carried out with appropriate controls.

TL;DR: Sera from Swedish patients with Hodgkin's disease as well as control sera from donors without known disease were titrated for antibodies to the EBV by the indirect immunofluorescence technique and an inverse relationship was found between the frequency of lymphoid cells and EBV‐associated serological reactivity.